PSG conducted a comprehensive survey of over 200 healthcare payers, including health plans and employers, to better understand their perspectives on the use of GLP-1s for treatment of obesity
Many of our patients experience not only weight loss but also enhanced energy, improved mobility, and a better quality of life
Endocrinology 153(3):15381547 Mansoor H, L BA, Morten D, Kathleen D, G EF, R FD et al (2019a) Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
In addition to changes at the formulary, benefit design and utilization management levels, successfully managing GLP-1 agonists requires extra support for members
Falsifications and unauthorised imitation products Criminals falsify the labels of commercially available pens or supply active substances that are still being researched as illegally manufactured preparations in some cases with potentially life-threatening consequences